New Key Statistics Module, Z-Score and F-Score
NAS:PIRS Key Ratios
| Market Cap $ M | 14.75 |
| Enterprise Value $ M | -11.53 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.55 |
| Price/Sales | 0.31 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 42.00 |
| EPS (TTM) $ | -22.40 |
| Beneish M-Score | 2.43 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 21.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.94 |
| EV-to-EBITDA | 1.13 |
| PEG | -- |
| Shares Outstanding M | 1.24 |
| Net Margin (%) | -57.33 |
| Operating Margin % | -28.57 |
| Pre-tax Margin (%) | -57.33 |
| Quick Ratio | 3.24 |
| Current Ratio | 3.24 |
| ROA % (ttm) | -33.77 |
| ROE % (ttm) | -86.94 |
| ROIC % (ttm) | -35.72 |
| Dividend Yield % | -- |
| Altman Z-Score | -10.81 |
PIRS Number of Guru Trades
PIRS Volume of Guru Trades
Gurus Latest Trades with NAS:PIRS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:PIRS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Pieris Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:PIRS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers